Search

everythinglearnresearchcommunity

for

Search:↓

Genetic variants in CYP genes may worsen PCOS symptoms.

Stopping finasteride and closing PFO can help prevent strokes in young adults.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Gender identity can be more diverse than just male or female.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Spironolactone treatment increases the amount of testosterone available in the body.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.